Tags: Drug.

Almorexant (INN codenamed ACT-078573) is an orexin antagonist functioning as a competitive receptor antagonist of the OX1 and OX2 orexin receptors which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia. Development of the drug was abandoned in January 2011.

Almorexant.svg
ATC prefix
none
CAS number
871224-64-5
FDA UNII code
9KCW39P2EI
IUPAC name
(2R)-2-[(1S)- 67-dimethoxy- 1-2-[4-(trifluoromethyl)phenyl]ethyl- 34-dihydroisoquinolin-2(1H)-yl]- N-methyl- 2-phenylacetamide
PubChem
23727689

Loading...

This page contains content from the copyrighted Wikipedia article "Almorexant"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.